Re-Vana
Company Details
Status: Private
Employees: 11-50
Location:
Belfast, United Kingdom
Type:
sample
Technology:
sample
sample
sample
sample
About: Re-Vana Therapeutics is a venture-backed, pioneering therapeutics and ocular
drug delivery company developing innovative sustained-release biologics to treat serious retinal diseases.
The company’s proprietary photo-crosslinked, biodegradable platform technologies, EyeLief®, EyeLief SD™ and OcuLief®, enable custom delivery of a wide range of therapeutic molecules.
Numerous platform capabilities create a therapeutic continuum to expand treatment opportunities through both internal development and external, strategic collaborations.
Re-Vana envisions a new industry standard for sustained delivery of biologics to the retina, creating transformative and differentiated treatments for physicians and significantly reducing patient treatment burden.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Re-Vana | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.